Rating Change
Morgan Stanley analysts upgraded Merck & Co., Inc. (NYSE:MRK) from Equal-Weight to Overweight on August 20, 2026.
upgradeNYSE:MRK
Merck & Co., Inc. (MRK) Upgraded to Overweight at Morgan Stanley
Morgan Stanley analysts upgraded Merck & Co., Inc. (NYSE:MRK) from Equal-Weight to Overweight on August 20, 2026.
At publication ·
What changed
Merck & Co., Inc. (NYSE:MRK) · upgrade
- Firm
- Morgan Stanley
- Rating
- Equal-Weight to Overweight
- Price at event
- $149.25
- Market capitalization
- $248.8B
At a glance
Key takeaways
- Morgan Stanley upgraded Merck & Co. (MRK) from Equal-Weight to Overweight on August 20, 2026, suggesting analysts see improving fundamentals or favorable risk-reward dynamics.
Market Context
Merck & Co., Inc. operates in the Healthcare sector. The stock currently trades at $149.25 with a market capitalization of $248.8B. The stock has gained 45.2% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Morgan Stanley's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Merck & Co., Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | UBS | Buy | N/A |
| Aug 20, 2026 | BMO Capital | Outperform | N/A |
| Aug 20, 2026 | RBC Capital | Sector Perform | N/A |
| Aug 20, 2026 | Morgan Stanley | Overweight | N/A |
| Aug 12, 2026 | Daiwa Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View MRK Stock Page
Frequently Asked Questions
What does the Overweight rating mean for MRK?
A rating of Overweight from Morgan Stanley reflects the analyst's outlook on Merck & Co., Inc. (NYSE:MRK). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MRK forecast page.
